ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Milan system for reporting salivary gland cytopathology

Milan system for reporting salivary gland cytopathology
Milan category Risk of malignancy[1]
(n = 485)		 Risk of malignancy[2]
(n = 12,898)		 Recommended management[2]
I: Nondiagnostic 12.5% 12.5% Clinical and radiological correlation/repeat FNAC
II: Non-neoplastic 0% 10.3% Clinical follow-up and radiological correlation
III: Atypia of unknown significance 33.3% 29% Repeat FNAC or surgery
IVA: Benign neoplasm 3.2% 2.3% Surgery or clinical follow-up
IVB: Salivary gland neoplasm of uncertain malignant potential 41.9% 28.6% Surgery
V: Suspicious for malignancy 100% 83% Surgery
VI: Malignant 100% 99.3% Surgery
FNAC: fine needle aspiration cytology.
References:
  1. Hosseini SM, Resta IT, Baloch ZW. Diagnostic performance of Milan system for reporting salivary gland cytopathology: A prospective study. Diagn Cytopathol 2021; 49:822.
  2. Reerds STH, Van Engen-Van Grunsven ACH, van den Hoogen FJA, et al. Accuracy of parotid gland FNA cytology and reliability of the Milan System for Reporting Salivary Gland Cytopathology in clinical practice. Cancer Cytopathol 2021; 129:719.
Graphic 135044 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟